Search
for
Sort by
Research 91–120 of 1000+
- Up in smoke: A neurologist's approach to “medical marijuana”
- Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Dermatologic Problems of Older Women
- Pharmacological Treatment of Alopecia
- The inflammatory component of androgenetic alopecia
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Medicine Update
- Polycystic Ovary Syndrome
- Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
- Therapeutic strategies for treating hair loss
- Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Faculty Opinions recommendation of Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- An industry update: what’s new in the field of therapeutic delivery this month?
- Thermo‐Responsive Polymer‐Based Nanoparticles: From Chemical Design to Advanced Applications
- Antiandrogens and Androgen Inhibitors
- ADVANCES IN PSORIASIS THERAPY
- Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
- Management of androgenetic alopecia: a review
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- What do we know about 5-alpha reductase inhibitors?
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Potential targets in the discovery of new hair growth promoters for androgenic alopecia
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Androgens/Androgen Receptor in the Management of Skin Diseases
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Lavenders, Their Phytochemical Properties, and Their Uses for Medical and Cosmetic Purposes
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma